Weird to say it about a nearly $150B company, but this could've been something of a game changer. Certainly a resounding success would've taken this upward 20% in the short term with huge cash streams to come. I get that it wasn't included in company forecasts, but it doesn't alter the fact that this does harm the medium term growth of the business given a lot of success is naturally priced into CSL.
Ann: Top-line Results from the Phase 3 AEGIS-II Trial, page-22
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$283.90 |
Change
4.320(1.55%) |
Mkt cap ! $136.9B | |||
| Open | High | Low | Value | Volume |
| $281.90 | $284.50 | $281.02 | $107.3M | 378.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 17779 | $312.29 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $255.51 | 313 | 1 |
View Market Depth
| Last trade - 15.59pm 15/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$283.87 |
Change
4.320 ( 1.68 %) |
||||
| Open | High | Low | Volume | ||
| $282.06 | $284.50 | $281.58 | 26577 | ||
| Last updated 15.59pm 15/05/2024 ? | |||||
| CSL (ASX) Chart |